197 related articles for article (PubMed ID: 22526544)
1. Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.
Sharma B; Singh N
Psychopharmacology (Berl); 2012 Oct; 223(3):307-17. PubMed ID: 22526544
[TBL] [Abstract][Full Text] [Related]
2. Salutary effect of NFκB inhibitor and folacin in hyperhomocysteinemia-hyperlipidemia induced vascular dementia.
Sharma B; Singh N
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):207-15. PubMed ID: 22510463
[TBL] [Abstract][Full Text] [Related]
3. Experimental hypertension induced vascular dementia: pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor.
Sharma B; Singh N
Pharmacol Biochem Behav; 2012 Jul; 102(1):101-8. PubMed ID: 22507914
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological benefit of I(1)-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease.
Gupta S; Sharma B
Brain Res Bull; 2014 Mar; 102():57-68. PubMed ID: 24582883
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of inducible nitric oxide synthase (iNOS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, convalesce behavior and biochemistry of hypertension induced vascular dementia in rats.
Sharma B; Singh N
Pharmacol Biochem Behav; 2013 Feb; 103(4):821-30. PubMed ID: 23201648
[TBL] [Abstract][Full Text] [Related]
6. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
Pu Q; Touyz RM; Schiffrin EL
J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the cardiovascular protection by omapatrilat and lisinopril treatments in DOCA-salt hypertension.
Millette E; Demeilliers B; Wu R; Laplante MA; El Midaoui A; Moreau P; Lamontagne D; de Champlain J
J Hypertens; 2003 Jan; 21(1):125-35. PubMed ID: 12544444
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats.
Sharma B; Singh N
Psychopharmacology (Berl); 2011 Jun; 215(4):677-87. PubMed ID: 21225418
[TBL] [Abstract][Full Text] [Related]
9. Prevention of hypertension-induced vascular dementia by Lactobacillus paracasei subsp. paracasei NTU 101-fermented products.
Cheng MC; Pan TM
Pharm Biol; 2017 Dec; 55(1):487-496. PubMed ID: 27937042
[TBL] [Abstract][Full Text] [Related]
10. Arsenic toxicity induced endothelial dysfunction and dementia: pharmacological interdiction by histone deacetylase and inducible nitric oxide synthase inhibitors.
Sharma B; Sharma PM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):180-8. PubMed ID: 23921152
[TBL] [Abstract][Full Text] [Related]
11. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/ cSRC pathway.
Wenceslau CF; Rossoni LV
J Hypertens; 2014 Mar; 32(3):542-54. PubMed ID: 24309491
[TBL] [Abstract][Full Text] [Related]
12. Preventive Beneficial Effect of an Aqueous Extract of Phyllanthus amarus Schum. and Thonn. (Euphorbiaceae) on DOCA-Salt-Induced Hypertension, Cardiac Hypertrophy and Dysfunction, and Endothelial Dysfunction in Rats.
Yao NA; Niazi ZR; Najmanová I; Kamagaté M; Said A; Chabert P; Auger C; Die-Kakou H; Schini-Kerth V
J Cardiovasc Pharmacol; 2020 Jun; 75(6):573-583. PubMed ID: 32187164
[TBL] [Abstract][Full Text] [Related]
13. Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats.
Nakano D; Itoh C; Ishii F; Kawanishi H; Takaoka M; Kiso Y; Tsuruoka N; Tanaka T; Matsumura Y
Biol Pharm Bull; 2003 Dec; 26(12):1701-5. PubMed ID: 14646174
[TBL] [Abstract][Full Text] [Related]
14. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension.
Gómez-Guzmán M; Jiménez R; Sánchez M; Zarzuelo MJ; Galindo P; Quintela AM; López-Sepúlveda R; Romero M; Tamargo J; Vargas F; Pérez-Vizcaíno F; Duarte J
Free Radic Biol Med; 2012 Jan; 52(1):70-9. PubMed ID: 22001745
[TBL] [Abstract][Full Text] [Related]
15. Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats.
Pu Q; Amiri F; Gannon P; Schiffrin EL
J Hypertens; 2005 Feb; 23(2):401-9. PubMed ID: 15662229
[TBL] [Abstract][Full Text] [Related]
16. Effects of equol on deoxycorticosterone acetate salt-induced hypertension and associated vascular dementia in rats.
Liu TH; Tsai TY
Food Funct; 2016 Aug; 7(8):3444-57. PubMed ID: 27435368
[TBL] [Abstract][Full Text] [Related]
17. Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats.
Nunes VW; Fortes ZB; Nigro D; Carvalho MH; Zorn TM; Scivoletto R
Gen Pharmacol; 2000 Feb; 34(2):117-25. PubMed ID: 10974419
[TBL] [Abstract][Full Text] [Related]
18. Ozagrel a thromboxane A2 synthase inhibitor extenuates endothelial dysfunction, oxidative stress and neuroinflammation in rat model of bilateral common carotid artery occlusion induced vascular dementia.
Bhatia P; Kaur G; Singh N
Vascul Pharmacol; 2021 Apr; 137():106827. PubMed ID: 33346090
[TBL] [Abstract][Full Text] [Related]
19. Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats.
Tyagi S; Sharma S; Budhiraja RD
Can J Physiol Pharmacol; 2012 Jul; 90(7):881-5. PubMed ID: 22731503
[TBL] [Abstract][Full Text] [Related]
20. Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes.
Sharma B; Singh N
Curr Neurovasc Res; 2010 Aug; 7(3):180-91. PubMed ID: 20560881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
